Trasidrex
5
relevant articles (0 outcomes,
2 trials/studies)
found for this Bio-Agent
Description:
contains 160 mg oxprenolol.HCl in sustained-release formulation & 0.25 mg cyclopenthiazide; reduces diastolic pressure
Also Known As:
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-, 1,1-dioxide, mixt. with 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-propanol hydrochloride
Bio-Agent Context: Research Results